Short answer
DENTSPLY SIRONA Inc (XRAY) filed an 8-K current report with the SEC on August 7, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition). Q2 fiscal 2026 results for quarter ended June 30, 2026.
DENTSPLY SIRONA Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 fiscal 2026 results for quarter ended June 30, 2026
- Press release Exhibit 99.1 contains the company’s financial results
- Investors should review the exhibit for revenue, earnings, guidance, and operating trends
Item EX-99.1 · Exhibit EX-99.1
- Q2 sales $898M, down 4.1% reported and 6.3% constant currency, signaling continued top-line pressure
- GAAP EPS $0.18 versus $(0.22), while adjusted EPS held at $0.52 despite adjusted EBITDA declining 3.3% to $190M
- Adjusted EBITDA margin improved to 21.3% from 21.1%, reflecting cost discipline amid weaker demand
- Orthodontic and Implant Solutions sales fell 13.2%, the largest segment decline, while Wellspect Healthcare grew 7.1%
- 2026 outlook maintained: sales $3.5B to $3.6B and adjusted EPS $1.40 to $1.50; $12M spent repurchasing 1.3M shares
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other DENTSPLY SIRONA Inc 8-K filings
Get the next XRAY 8-K as it lands
Follow XRAY for push alerts, or ask the research agent what this filing means.